Less is not always more
As my wife and I were returning by train from "The City" last night (if you need to ask "which city?" you don't live on the east coast), we were listening to a group of teenagers. It was satisfying to...
View ArticleSounds the same; acts the same?
I'm in New Orleans for PittCon 2008. I was teasing a saleslady who was yawning at midday, when I learned something. She was tired from going out after work, buying as much bread and "fillins" as she...
View ArticleThe whipping boy
Are health costs too high? Yes! Are the pharmaceutical industry-types to blame? Not so much. The "cost" of health care that includes drugs is only a small fraction of what we spend. The far greatest...
View ArticleWe have met the enemy and he is us…
A few years ago the American Cancer Society used vanity to help women stop smoking. Apparently, cancer, stroke, and heart disease weren't convincing them to quit, so the ACS used vanity: it disclosed...
View ArticleTy Pennington's "Extreme Makeover: FDA Edition"
Shire Development (Wayne, PA) has received a warning letter from FDA for what the agency says are overstatements of the efficacy and understatements of the risk of Adderall XR, the firm's popular ADHD...
View ArticleTwo Congressmen Endorse Peter Rost for FDA Commissioner
I thought the whole "Rost for FDA Chief" that surfaced after John Mack's recent poll was a joke, but then read that Dr. Rost, who emerged as the favorite candidate in that poll, has received the...
View ArticleView from Academia: "Scale Is Not Going to Do It" for Pharma's Future
University of Pennsylvania's Wharton School regularly publishes insights into how the pharmaceutical industry is faring, and its most recent article is the naively titled, "Rx for the Pharmaceutical...
View ArticleBeware of FDA "Special Agents," At Least When They Call on the Phone
For those adamantly opposed to the burgeoning market for purchasing meds over the Internet, here is more fodder for your arguments: FDA has issued a warning that cybercriminals posing as FDA "special...
View ArticleThe Pharmaceutical Industry in Figures
EFPIA's annual report on the pharmaceutical industry in figures is now available, a 40-page, chart-filled conglomeration of data on the industry within the EU and how it compares to the global drug...
View ArticlePharma (and Everyone Else) Asks: What Would Steve Do?
The passing of Steve Jobs has been an opportunity for just about everyone (okay, maybe everyone) to assess his significance and ponder the lessons he taught. Blogs (like this one) seem to see it as an...
View Article